Edward Lifesciences Down 9% Despite Q4 Beat
February 02, 2017 at 11:42 AM EST
Edwards Lifesciences Corp (NYSE: ES) shares are trading lower by $9.00 at $89.02 in Thursday's session. Despite a Q4 EPS beat ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.